• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者随机化移动技术生活方式方案的实施。

Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of California San Diego, 9350 Campus Point Dr Ste 2B #0975, San Diego, CA, USA.

Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

出版信息

Sci Rep. 2024 Mar 28;14(1):7452. doi: 10.1038/s41598-024-57722-7.

DOI:10.1038/s41598-024-57722-7
PMID:38548875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10978851/
Abstract

Identifying effective, feasible, low-cost interventions that promote sustainable lifestyle changes in nonalcoholic fatty liver disease (NAFLD) is a key unmet need. The aim of this study was to assess predictors of lifestyle practice patterns of NAFLD patients and evaluate the implementation of a mobile technology-based intervention. We prospectively enrolled adults with NAFLD (diagnosed by imaging or biopsy). Individuals with additional liver diseases or decompensated cirrhosis were excluded. Patient were randomized to usual care or a FitBit based program for 6-months. We obtained anthropometrics, labs, vibration controlled transient elastography (VCTE), health-related quality of life (HRQOL), physical activity, diet and motivation to change data. 70 patients were enrolled, 33% with cirrhosis. Median age was 52.1 years, 47% males, 83% white, body mass index 32.3, liver stiffness 7.6 kPa, controlled attenuation parameter 319 db/m, and 50% had diabetes. Baseline HRQOL was 5.4/7 and independently negatively correlated with level of concern about their disease and positively with physical function. Younger age was independently associated with unhealthy diets whereas diabetes was independently associated with unhealthy diets and higher VCTE kPa. 6-month follow-up data available on 31 patients showed trends in improvement in weight. In a cohort of NAFLD patients, we identified independent correlates of lifestyle behaviors and HRQOL. Implementation of interventions that improve physical function may improve HRQOL in NAFLD. Younger patients and those with diabetes appeared to have the greatest need for dietary interventions. Structured mobile technology lifestyle interventions using Fitbit and personalized coaching showed promise but require further validation with a focus on sustainability of intervention and improvement in outcomes.

摘要

确定有效的、可行的、低成本的干预措施,以促进非酒精性脂肪性肝病(NAFLD)患者可持续的生活方式改变,是一个关键的未满足需求。本研究的目的是评估 NAFLD 患者生活方式实践模式的预测因素,并评估基于移动技术的干预措施的实施情况。我们前瞻性地招募了患有 NAFLD 的成年人(通过影像学或活检诊断)。排除了有其他肝脏疾病或失代偿性肝硬化的患者。患者被随机分配到常规护理或基于 FitBit 的方案中,为期 6 个月。我们获取了人体测量学、实验室、振动控制瞬态弹性成像(VCTE)、健康相关生活质量(HRQOL)、身体活动、饮食和改变动机的数据。共纳入 70 例患者,33%的患者患有肝硬化。中位年龄为 52.1 岁,47%为男性,83%为白人,体重指数为 32.3,肝硬度为 7.6kPa,受控衰减参数为 319db/m,50%的患者患有糖尿病。基线 HRQOL 为 5.4/7,与对疾病的关注程度呈负相关,与身体功能呈正相关。年龄较轻与不健康饮食独立相关,而糖尿病与不健康饮食和更高的 VCTE kPa 独立相关。31 例患者的 6 个月随访数据显示体重呈改善趋势。在 NAFLD 患者队列中,我们确定了生活方式行为和 HRQOL 的独立相关因素。改善身体功能的干预措施可能会改善 NAFLD 的 HRQOL。年轻患者和患有糖尿病的患者似乎对饮食干预的需求最大。使用 Fitbit 和个性化指导的结构化移动技术生活方式干预措施显示出前景,但需要进一步验证,重点是干预的可持续性和结局的改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1886/10978851/390a537ebb38/41598_2024_57722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1886/10978851/c442a02136bd/41598_2024_57722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1886/10978851/390a537ebb38/41598_2024_57722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1886/10978851/c442a02136bd/41598_2024_57722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1886/10978851/390a537ebb38/41598_2024_57722_Fig2_HTML.jpg

相似文献

1
Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者随机化移动技术生活方式方案的实施。
Sci Rep. 2024 Mar 28;14(1):7452. doi: 10.1038/s41598-024-57722-7.
2
Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.基于试点的结构化移动技术的生活方式干预对非酒精性脂肪性肝病患者的影响。
Dig Dis Sci. 2022 Feb;67(2):481-491. doi: 10.1007/s10620-021-06922-6. Epub 2021 May 3.
3
When the liver gets stiff, the tough get moving.当肝脏变硬,坚韧的人就会行动起来。
J Gastroenterol Hepatol. 2020 Jun;35(6):953-959. doi: 10.1111/jgh.14963. Epub 2020 Feb 11.
4
Clinical Performance of Transient Elastography With Comparison to Quantitative Magnetic Resonance Imaging, Ultrasound, and Biopsy in Children and Adolescents With Known or Suspected Fatty Liver Disease.瞬时弹性成像技术在儿童和青少年已知或疑似脂肪肝中的临床性能与定量磁共振成像、超声和肝活检的比较。
Child Obes. 2023 Oct;19(7):461-469. doi: 10.1089/chi.2022.0136. Epub 2022 Oct 20.
5
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.
6
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.一项关于 2 型糖尿病患者非酒精性脂肪性肝病、肝纤维化、肝硬化和肝细胞癌患病率的前瞻性研究。
J Hepatol. 2023 Mar;78(3):471-478. doi: 10.1016/j.jhep.2022.11.010. Epub 2022 Nov 19.
7
The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound.应用控幅振动瞬时弹性成像技术筛查的中国成年人非酒精性脂肪性肝病患病率及其与超声检查的诊断差异。
Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):101951. doi: 10.1016/j.clinre.2022.101951. Epub 2022 May 21.
8
Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography.使用非酒精性脂肪性肝病纤维化评分和振动控制瞬时弹性成像对非酒精性脂肪性肝病进行成本效益评估。
Am J Gastroenterol. 2015 Sep;110(9):1298-304. doi: 10.1038/ajg.2015.241. Epub 2015 Aug 25.
9
Clinical implications of hepatic structure and function evaluation based on vibration-controlled transient elastography and liver maximum function capacity test in patients with nonalcoholic fatty liver disease.基于振动控制瞬时弹性成像和肝脏最大功能容量测试对非酒精性脂肪性肝病患者进行肝脏结构和功能评估的临床意义
Eur J Gastroenterol Hepatol. 2022 Jun 1;34(6):686-692. doi: 10.1097/MEG.0000000000002347. Epub 2022 Jan 31.
10
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.经瞬时弹性成像定义的非酒精性脂肪性肝病患者中显著纤维化的患病率及预测因素
Dig Dis Sci. 2017 Aug;62(8):2150-2158. doi: 10.1007/s10620-017-4592-0. Epub 2017 May 18.

引用本文的文献

1
eHealth interventions and patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.电子健康干预措施与代谢功能障碍相关脂肪性肝病患者:一项系统评价与荟萃分析
BMJ Open Gastroenterol. 2025 Apr 9;12(1):e001670. doi: 10.1136/bmjgast-2024-001670.
2
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome - current insights and future directions.从肥胖到脂肪变性:代谢功能障碍相关脂肪性肝病,代谢综合征的肝脏表现——当前见解与未来方向
Clin Diabetes Endocrinol. 2024 Dec 2;10(1):39. doi: 10.1186/s40842-024-00187-4.

本文引用的文献

1
The effects of electronic-based lifestyle interventions on nonalcoholic fatty liver disease: A systematic review.基于电子设备的生活方式干预对非酒精性脂肪性肝病的影响:一项系统综述。
Digit Health. 2023 Jul 28;9:20552076231187597. doi: 10.1177/20552076231187597. eCollection 2023 Jan-Dec.
2
The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.电子健康干预措施对非酒精性脂肪性肝病患者生活方式改变的效果:系统评价和荟萃分析。
J Med Internet Res. 2023 Jan 23;25:e37487. doi: 10.2196/37487.
3
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.
全球非酒精性脂肪性肝病的患病率和发病率:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5.
4
Effects of Bariatric Endoscopy on Non-Alcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Meta-Analysis.减重内镜治疗非酒精性脂肪性肝病的效果:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2022 Jun 17;13:931519. doi: 10.3389/fendo.2022.931519. eCollection 2022.
5
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.成人超重和肥胖的药物治疗:随机对照试验的系统评价和网状荟萃分析
Lancet. 2022 Jan 15;399(10321):259-269. doi: 10.1016/S0140-6736(21)01640-8. Epub 2021 Dec 8.
6
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.减肥手术与经活检证实的非酒精性脂肪性肝炎患者的肝脏和心血管主要不良结局的关联
JAMA. 2021 Nov 23;326(20):2031-2042. doi: 10.1001/jama.2021.19569.
7
Patient disease knowledge, attitudes and behaviours related to non-alcoholic fatty liver disease: a qualitative study.患者对非酒精性脂肪性肝病的疾病知识、态度和行为:一项定性研究。
BMJ Open Gastroenterol. 2021 Jun;8(1). doi: 10.1136/bmjgast-2021-000634.
8
Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.非酒精性脂肪性肝病患者的疾病知识、健康相关生活质量和生活方式行为改变:教育干预的影响。
Dig Dis Sci. 2022 Jun;67(6):2123-2133. doi: 10.1007/s10620-021-07052-9. Epub 2021 May 27.
9
Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.基于试点的结构化移动技术的生活方式干预对非酒精性脂肪性肝病患者的影响。
Dig Dis Sci. 2022 Feb;67(2):481-491. doi: 10.1007/s10620-021-06922-6. Epub 2021 May 3.
10
Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.打破非酒精性脂肪性肝病患者身体活动障碍。
Dig Dis Sci. 2021 Oct;66(10):3604-3611. doi: 10.1007/s10620-020-06673-w. Epub 2020 Oct 23.